OpenAlex
PricingAboutJobs
Log inGet started
Work

Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors

HTML

Year: 2017
Type: other
Source: Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.7b00360
Authors: Ken A. Brameld, Timothy D. Owens, Erik Verner, Eleni Venetsanakos, J. Michael Bradshaw, Vernon T. Phan, Danny Tam, Kwan Leung, Jin Shu, Jacob LaStant, David G. Loughhead, Tony Ton, Dane E. Karr, Mary E. Gerritsen, David M. Goldstein, Jens Oliver Funk
Institution: Principia Biopharma (United States)
Language: English

Topic: Fibroblast Growth Factor Research
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: FGFR inhibitors, irreversible covalent inhibitors, fibroblast growth factor receptor, FGFR1-4, solid tumors, structure-based drug design, ADME properties, anticancer drug discovery, pyrido[2,3-d]pyrimidinone
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2724796663
Cites: 45
Cited by: 108
Related to: 10
Parts: 2
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security